AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Profit Over Healing: The Pharmaceutical Industry's Motivations
This chapter explores the pharmaceutical industry's prioritization of profit over patient care, questioning the motives behind treatment decisions. It highlights the FDA's recent rejection of MDMA therapy for PTSD, revealing systemic issues and the need for collective action to foster change in mental health treatment.